Role of peroxisome proliferator-activated receptor gamma coactivator 1 in AKT/PKB-Mediated inhibition of hepatitis b virus biosynthesis

Journal of Virology

Volumn 85, Issue 22, 2011, Pages 11891-11900

  Ondracek, Caitlin R ^a   McLachlan, Alan ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIVER RECEPTOR HOMOLOG 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PHOSPHOINOSITIDE DEPENDENT PROTEIN KINASE 1; PROTEIN KINASE B;

ARTICLE; CELL STRAIN HEK293; CONTROLLED STUDY; HEPATITIS B VIRUS; HEPATOMA CELL; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; RNA SYNTHESIS; SIGNAL TRANSDUCTION; VIRUS REPLICATION; VIRUS TRANSCRIPTION;

CELL LINE; HEAT-SHOCK PROTEINS; HEPATITIS B VIRUS; HOST-PATHOGEN INTERACTIONS; HUMANS; PROTO-ONCOGENE PROTEINS C-AKT; TRANSCRIPTION FACTORS; VIRUS REPLICATION;

HEPATITIS B VIRUS; MURINAE;

EID: 80655125493     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00832-11     Document Type: Article

References (58)

1. Beasley, R. P. 1988. Hepatitis B virus: the major etiology of hepatocellular carcinoma. Cancer 61:1942-1956.
2. Beasley, R. P., L.-Y. Hwang, C.-C. Lin, and C.-S. Chien. 1981. Hepatocellular carcinoma and hepatitis B virus-a prospective study of 22707 men in Taiwan. Lancet ii:1129-1133.
3. Bhaskar, P. T., and N. Hay. 2007. The two TORCs and Akt. Dev. Cell 12:487-502.
4. Boyault, S., et al. 2007. Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets. Hepatology (Baltimore, Md.) 45:42-52.
5. Cantley, L. C., and B. G. Neel. 1999. New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway. Proc. Natl. Acad. Sci. U. S. A. 96:4240-4245.
6. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159.
7. Cooper, M. P., et al. 2006. Defects in energy homeostasis in Leigh syndrome French Canadian variant through PGC-1α/LRP130 complex. Genes Dev. 20:2996-3009.
8. Craxi, A., et al. 1984. Tissue markers of hepatitis B virus infection in hepatocellular carcinoma and cirrhosis. Hepatogastroenterology 31:55-59.
9. Daub, H., et al. 2002. Identification of SRPK1 and SRPK2 as the major cellular protein kinases phosphorylating hepatitis B virus core protein. J. Virol. 76:8124-8137.
10. Dubois, M. F., C. Pourcel, S. Rousset, C. Chany, and P. Tiollais. 1980. Excretion of hepatitis B surface antigen particles from mouse cells transformed with cloned viral DNA. Proc. Natl. Acad. Sci. U. S. A. 77:4549-4553.
11. Gazina, E. V., J. E. Fielding, B. Lin, and D. A. Anderson. 2000. Core protein phosphorylation modulates pregenomic RNA encapsidation to different extents in human and duck hepatitis B viruses. J. Virol. 74:4721-4728.
12. Guo, H., et al. 2007. Regulation of hepatitis B virus replication by the phosphatidylinositol 3-kinase-Akt signal transduction pathway. J. Virol. 81: 10072-10080.
13. Hay, N. 2011. Akt isoforms and glucose homeostasis-the leptin connection. Trends Endocrinol. Metab. 22:66-73.
14. Hsu, H. C., W. S. Lin, and M. J. Tsai. 1983. Hepatitis-B surface antigen and hepatocellular carcinoma in Taiwan. With special reference to types and localization of HBsAg in the tumor cells. Cancer 52:1825-1832.
15. Jager, S., C. Handschin, J. Pierre, and B. M. Spiegelman. 2007. AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1α. Proc. Natl. Acad. Sci. U. S. A. 104:12017-12022.
16. Kennedy, S. G., et al. 1997. The PI 3-kinase/Akt signaling pathway delivers an anti-apoptotic signal. Genes Dev. 11:701-713.
17. Köck, J., M. Nassal, K. Deres, H. E. Blum, and F. Von Weizsäcker. 2004. Hepatitis B virus nucleocapsids formed by carboxy-terminally mutated core proteins contain spliced viral genomes but lack full-size DNA. J. Virol. 78:13812-13818.
18. Kosovsky, M. J., I. Qadri, and A. Siddiqui. 1998. The regulation of hepatitis B virus gene expression: an overview of the cis- and trans-acting components, p. 21-50. In R. Koshy and W. H. Caselmann (ed.), Hepatitis B virus: molecular mechanisms in disease and novel strategies for therapy. Imperial College Press, London, United Kingdom.
19. Kroczynska, B., S. Kaur, and L. C. Platanias. 2010. Growth suppressive cytokines and the AKT/mTOR pathway. Cytokine 48:138-143.
20. Lai, M. Y., et al. 1988. Status of hepatitis B virus DNA in hepatocellular carcinoma: a study based on paired tumor and nontumor liver tissues. J. Med. Virol. 25:249-258.
21. Lan, Y. T., J. Li, W. Y. Liao, and J. H. Ou. 1999. Roles of the three major phosphorylation sites of hepatitis B virus core protein in viral replication. Virology 259:342-348.
22. Li, L., et al. 2009. Developmental regulation of hepatitis B virus biosynthesis by hepatocyte nuclear factor 4α. PLoS One 4:e5489.
23. Li, X., B. Monks, Q. Ge, and M. J. Birnbaum. 2007. Akt/PKB regulates hepatic metabolism by directly inhibiting PGC-1α transcription coactivator. Nature 447:1012-1016.
24. Liao, W., and J.-H. Ou. 1995. Phosphorylation and nuclear localization of the hepatitis B virus core protein: significance of serine in the three repeated SPRRR motifs. J. Virol. 69:1025-1029.
25. Lin, J., C. Handschin, and B. M. Spiegelman. 2005. Metabolic control through the PGC-1 family of transcription coactivators. Cell Metab. 1:361-370.
26. Lu, T. T., et al. 2000. Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors. Mol. Cell 6:507-515.
27. Machida, A., et al. 1991. Phosphorylation in the carboxyl-terminal domain of the capsid protein of hepatitis B virus: evaluation with a monoclonal antibody. J. Virol. 65:6024-6030.
28. Manning, B. D., and L. C. Cantley. 2007. AKT/PKB signaling: navigating downstream. Cell 129:1261-1274.
29. McLachlan, A., et al. 1987. Expression of hepatitis B virus surface and core antigens: influences of pre-S and precore sequences. J. Virol. 61:683-692.
30. Nassal, M. 1992. The arginine-rich domain of the hepatitis B virus core protein is required for pregenome encapsidation and productive viral positive-strand DNA synthesis but not for virus assembly. J. Virol. 66:4107-4116.
31. Neuveut, C., Y. Wei, and M. A. Buendia. 2010. Mechanisms of HBV-related hepatocarcinogenesis. J. Hepatol. 52:594-604.
32. Nogueira, V., et al. 2008. Akt determines replicative senescence and oxidative or oncogenic premature senescence and sensitizes cells to oxidative apoptosis. Cancer Cell 14:458-470.
33. Olson, B. L., et al. 2008. SCFCdc4 acts antagonistically to the PGC-1α transcriptional coactivator by targeting it for ubiquitin-mediated proteolysis. Genes Dev. 22:252-264.
34. Ondracek, C. R., V. C. Reese, C. N. Rushing, C. E. Oropeza, and A. McLachlan. 2009. Distinct regulation of hepatitis B virus biosynthesis by peroxisome proliferator-activated receptor γ coactivator 1α and small heterodimer partner in human hepatoma cell lines. J. Virol. 83:12545-12551.
35. Ondracek, C. R., C. N. Rushing, V. C. Reese, C. E. Oropeza, and A. McLachlan. 2009. Peroxisome proliferator-activated receptor γ coactivator 1α and small heterodimer partner differentially regulate nuclear receptordependent hepatitis B virus biosynthesis. J. Virol. 83:12535-12544.
36. Puigserver, P., et al. 2001. Cytokine stimulation of energy expenditure through p38 MAP kinase activation of PPARgamma coactivator-1. Mol. Cell 8:971-982.
37. Raney, A. K., J. L. Johnson, C. N. A. Palmer, and A. McLachlan. 1997. Members of the nuclear receptor superfamily regulate transcription from the hepatitis B virus nucleocapsid promoter. J. Virol. 71:1058-1071.
38. Reese, V. C., et al. 2011. Multiple nuclear receptors may regulate hepatitis B virus biosynthesis during development. Int. J. Biochem. Cell Biol. 43:230-237.
39. Rhee, J., et al. 2003. Regulation of hepatic fasting response by PPARγ coactivator-1α (PGC-1): requirement for hepatocyte nuclear factor 4α in gluconeogenesis. Proc. Natl. Acad. Sci. U. S. A. 100:4012-4017.
40. Rodgers, J. T., W. Haas, S. P. Gygi, and P. Puigserver. 2010. Cdc2-like kinase 2 is an insulin-regulated suppressor of hepatic gluconeogenesis. Cell Metab. 11:23-34.
41. Rohas, L. M., et al. 2007. A fundamental system of cellular energy homeostasis regulated by PGC-1α. Proc. Natl. Acad. Sci. U. S. A. 104:7933-7938.
42. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
43. Shlomai, A., N. Paran, and Y. Shaul. 2006. PGC-1α controls hepatitis B virus through nutritional signals. Proc. Natl. Acad. Sci. U. S. A. 103:16003-16008.
44. Shlomai, A., and Y. Shaul. 2008. The "metabolovirus" model of hepatitis B virus suggests nutritional therapy as an effective anti-viral weapon. Med. Hypotheses 71:53-57.
45. Summers, J., and W. S. Mason. 1982. Replication of the genome of a hepatitis B-like virus by reverse transcription of an RNA intermediate. Cell 29:403-415.
46. Summers, J., P. M. Smith, M. Huang, and M. Yu. 1991. Morphogenetic and regulatory effects of mutations in the envelope proteins of an avian hepadnavirus. J. Virol. 65:1310-1317.
47. Tang, H., K. E. Banks, A. L. Anderson, and A. McLachlan. 2001. Hepatitis B virus transcription and replication. Drug News Perspect. 14:325-334.
48. Tang, H., and A. McLachlan. 2001. Transcriptional regulation of hepatitis B virus by nuclear hormone receptors is a critical determinant of viral tropism. Proc. Natl. Acad. Sci. U. S. A. 98:1841-1846.
49. Tsai, W. L., and R. T. Chung. 2010. Viral hepatocarcinogenesis. Oncogene 29:2309-2324.
50. Tucker, M. E. 3 March 2011. Acute hepatitis B incidence double in people with diabetes. Intern. Med. News. http://www.internalmedicinenews.com.
51. Walther, Z., and J. Sklar. 2011. Molecular tumor profiling for prediction of response to anticancer therapies. Cancer J. 17:71-79.
52. Wang, Y., et al. 2002. Different expression of hepatitis B surface antigen between hepatocellular carcinoma and its surrounding liver tissue, studied using a tissue microarray. J. Pathol. 197:610-616.
53. Wen, S., et al. 2001. PTEN controls tumor-induced angiogenesis. Proc. Natl. Acad. Sci. U. S. A. 98:4622-4627.
54. Whiteman, E. L., H. Cho, and M. J. Birnbaum. 2002. Role of Akt/protein kinase B in metabolism. Trends Endocrinol. Metab. 13:444-451.
55. Whittaker, S., R. Marais, and A. X. Zhu. 2010. The role of signaling pathways in the development and treatment of hepatocellular carcinoma. Oncogene 29:4989-5005.
56. Will, H., et al. 1987. Replication strategy of human hepatitis B virus. J. Virol. 61:904-911.
57. Xiong, S., et al. 2010. PGC-1α serine 570 phosphorylation and GCN5-mediated acetylation by angiotensin II drive catalase down-regulation and vascular hypertrophy. J. Biol. Chem. 285:2474-2487.
58. Yoon, J. C., et al. 2001. Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1. Nature 413:131-138.